North America Organoids Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Stomach, Intestine, Liver, Pancreas, Lung, Brain, Kidney, and Others), Application (Developmental Biology, Disease Pathology of Infectious Disease, Regenerative Medicine, Drug Toxicity & Efficacy Testing, Drug Discovery & Personalized Medicine, and Others), and Source (Pluripotent Stem Cells and Organ-specific Adult Stem Cells)
The North America organoids market is expected to grow from US$ 1,357.19 million in 2023 to US$ 3,585.62 million by 2028. It is estimated to record a CAGR of 21.4% from 2023 to 2028.
Growing Adoption of Personalized Drugs Fuels North America Organoids Market
Personalized medicine, also known as precision medicine, is a medical model that practices procedures or drugs tailored to the individual patient based on the projected response or risk of disease. According to the latest report by the PMC (published in 2021), in the US, the number of personalized medicines in the market has risen from 132 in 2016 to 286 in 2020. The data was shared by tracking the numbers of personalized medicine since 2008 by the PMC.
The implementation of organoids to create personalized drug therapies provides exciting opportunities for improving patient care. In addition, pharmacists play an essential role in increasing the demand for personalized medicines as they proactively educate and create awareness about precision medicine. This demand has persuaded pharmaceutical research to develop more tailored treatments to make medicines safer and more effective.
Personalized cancer medicine is an approach to tailoring effective therapeutic strategies for each patient according to a tumor’s genomic characterization. There is an increasing demand for research in personalized tumor modeling to confirm the functional aspects of genomic drug response predictions in the preclinical setting. Numerous studies have highlighted the application of tumor organoids in personalized cancer medicine in terms of gene-drug association treatment, identification of new therapies, and prediction of patient outcomes.
Personalized cancer therapy applies specific treatments to each patient. Using personalized tumor models with similar characteristics to the original tumors might result in accurate predictions of drug responses in patients. Tumor organoid models have several advantages, such as conserving the molecular and cellular composition of the original tumor over pre-existing models. These advantages highlight the tremendous potential of tumor organoids in personalized cancer therapy, particularly in preclinical drug screening and predicting patient responses to selected treatment regimens.
North America Organoids Market Overview
The North America organoids market is segmented into the US, Canada, and Mexico. In 2022, the US held the largest share of the North America organoids market. The rising number of patients suffering from chronic conditions and viral diseases, increasing activities in research and development, growing commercialization of organoid models, and surging breakthroughs in stem cell research are the key factors propelling the market for organoids. Also, the growing funding and grants for organoid development are contributing to the growth of the market.
North America Organoids Market Revenue and Forecast to 2028 (US$ Million)
North America Organoids Market Segmentation
The North America organoids market is segmented on the basis of type, application, source, and country.
Based on type, the market is segmented into stomach, intestine, liver, pancreas, lung, brain, kidney, and others. The intestine segment registered the largest market share in 2023.
Based on application, the North America organoids market is segmented into developmental biology disease, pathology of infectious disease, regenerative medicine, drug toxicity and efficacy testing, drug discovery and personalized medicine, and others. The developmental biology disease segment held the largest market share in 2023.
Based on source, the North America organoids market is bifurcated into pluripotent stem cells and organ-specific adult stem cells. The pluripotent stem cells segment held a larger market share in 2023.
Based on country, the North America organoids market is segmented into the US, Canada, and Mexico. The US dominated the market share in 2023.
Corning Inc; Definigen; InSphero; Merck kGaA; Organoid Therapeutics; PeproTech, Inc.; STEMCELL Technologies Inc; and Thermo Fisher Scientific Inc are the leading companies operating in the organoids market in North America.
Growing Adoption of Personalized Drugs Fuels North America Organoids Market
Personalized medicine, also known as precision medicine, is a medical model that practices procedures or drugs tailored to the individual patient based on the projected response or risk of disease. According to the latest report by the PMC (published in 2021), in the US, the number of personalized medicines in the market has risen from 132 in 2016 to 286 in 2020. The data was shared by tracking the numbers of personalized medicine since 2008 by the PMC.
The implementation of organoids to create personalized drug therapies provides exciting opportunities for improving patient care. In addition, pharmacists play an essential role in increasing the demand for personalized medicines as they proactively educate and create awareness about precision medicine. This demand has persuaded pharmaceutical research to develop more tailored treatments to make medicines safer and more effective.
Personalized cancer medicine is an approach to tailoring effective therapeutic strategies for each patient according to a tumor’s genomic characterization. There is an increasing demand for research in personalized tumor modeling to confirm the functional aspects of genomic drug response predictions in the preclinical setting. Numerous studies have highlighted the application of tumor organoids in personalized cancer medicine in terms of gene-drug association treatment, identification of new therapies, and prediction of patient outcomes.
Personalized cancer therapy applies specific treatments to each patient. Using personalized tumor models with similar characteristics to the original tumors might result in accurate predictions of drug responses in patients. Tumor organoid models have several advantages, such as conserving the molecular and cellular composition of the original tumor over pre-existing models. These advantages highlight the tremendous potential of tumor organoids in personalized cancer therapy, particularly in preclinical drug screening and predicting patient responses to selected treatment regimens.
North America Organoids Market Overview
The North America organoids market is segmented into the US, Canada, and Mexico. In 2022, the US held the largest share of the North America organoids market. The rising number of patients suffering from chronic conditions and viral diseases, increasing activities in research and development, growing commercialization of organoid models, and surging breakthroughs in stem cell research are the key factors propelling the market for organoids. Also, the growing funding and grants for organoid development are contributing to the growth of the market.
North America Organoids Market Revenue and Forecast to 2028 (US$ Million)
North America Organoids Market Segmentation
The North America organoids market is segmented on the basis of type, application, source, and country.
Based on type, the market is segmented into stomach, intestine, liver, pancreas, lung, brain, kidney, and others. The intestine segment registered the largest market share in 2023.
Based on application, the North America organoids market is segmented into developmental biology disease, pathology of infectious disease, regenerative medicine, drug toxicity and efficacy testing, drug discovery and personalized medicine, and others. The developmental biology disease segment held the largest market share in 2023.
Based on source, the North America organoids market is bifurcated into pluripotent stem cells and organ-specific adult stem cells. The pluripotent stem cells segment held a larger market share in 2023.
Based on country, the North America organoids market is segmented into the US, Canada, and Mexico. The US dominated the market share in 2023.
Corning Inc; Definigen; InSphero; Merck kGaA; Organoid Therapeutics; PeproTech, Inc.; STEMCELL Technologies Inc; and Thermo Fisher Scientific Inc are the leading companies operating in the organoids market in North America.
1. INTRODUCTION
1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Organoids Market – by Type
1.3.2 North America Organoids Market – by Application
1.3.3 North America Organoids Market – by Source
1.3.4 North America Organoids Market – by Country
2. NORTH AMERICA ORGANOIDS MARKET – KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. NORTH AMERICA ORGANOIDS MARKET – MARKET LANDSCAPE
4.1 Overview
4.2 North America PEST Analysis
4.3 Expert’s Opinion
5. NORTH AMERICA ORGANOIDS MARKET – KEY MARKET DYNAMICS
5.1 Market Drivers
5.1.1 Increasing Demand for Tumor Modelling and Biobanking
5.1.2 Growing Adoption of Personalized Drugs
5.1.3 Rising Focus on Developing Alternatives for Animal Testing Models
5.2 Market Restraints
5.2.1 Issues Related to Incorporation of Organoids into Existing Workflows
5.2.2 Dearth of Skilled Professionals
5.3 Market Opportunities
5.3.1 Focus on Drug Discovery Activities
5.4 Future Trends
5.4.1 Combining Organoid with Organ-On-A-Chip
5.5 Impact Analysis
6. ORGANOIDS MARKET – NORTH AMERICA ANALYSIS
6.1 North America Organoids Market Revenue Forecast and Analysis
7. NORTH AMERICA ORGANOIDS MARKET – REVENUE AND FORECAST TO 2028 – BY TYPE
7.1 Overview
7.2 North America Organoids Market Revenue Share, by Type (2022 and 2028)
7.3 Stomach
7.3.1 Overview
7.3.2 Stomach: North America Organoids Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Intestine
7.4.1 Overview
7.4.2 Intestine: North America Organoids Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Liver
7.5.1 Overview
7.5.2 Liver: North America Organoids Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Pancreas
7.6.1 Overview
7.6.2 Pancreas: North America Organoids Market – Revenue and Forecast to 2028 (US$ Million)
7.7 Lung
7.7.1 Overview
7.7.2 Lung: North America Organoids Market – Revenue and Forecast to 2028 (US$ Million)
7.8 Brain
7.8.1 Overview
7.8.2 Brain: North America Organoids Market – Revenue and Forecast to 2028 (US$ Million)
7.9 Kidney
7.9.1 Overview
7.9.2 Kidney: North America Organoids Market – Revenue and Forecast to 2028 (US$ Million)
7.10 Others
7.10.1 Overview
7.10.2 Others: North America Organoids Market – Revenue and Forecast to 2028 (US$ Million)
8. NORTH AMERICA ORGANOIDS MARKET – REVENUE AND FORECAST TO 2028 – BY APPLICATION
8.1 Overview
8.2 North America Organoids Market Revenue Share, by Application (2022 and 2028)
8.3 Developmental Biology
8.3.1 Overview
8.3.2 Developmental Biology: North America Organoids Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Disease Pathology of Infectious Disease
8.4.1 Overview
8.4.2 Disease Pathology of Infectious Disease: North America Organoids Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Regenerative Medicine
8.5.1 Overview
8.5.2 Regenerative Medicine: North America Organoids Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Drug Toxicity and Efficacy Testing
8.6.1 Overview
8.6.2 Drug Toxicity and Efficacy Testing: North America Organoids Market – Revenue and Forecast to 2028 (US$ Million)
8.7 Drug Discovery and Personalized Medicine
8.7.1 Overview
8.7.2 Drug Discovery and Personalized Medicine: North America Organoids Market – Revenue and Forecast to 2028 (US$ Million)
8.8 Others
8.8.1 Overview
8.8.2 Others: North America Organoids Market – Revenue and Forecast to 2028 (US$ Million)
9. NORTH AMERICA ORGANOIDS MARKET – REVENUE AND FORECAST TO 2028 – BY SOURCE
9.1 Overview
9.2 North America Organoids Market Revenue Share, by Source (2022and 2028)
9.3 Pluripotent Stem Cells
9.3.1 Overview
9.3.2 Pluripotent Stem Cells: North America Organoids Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Organ-specific Adult Stem Cells
9.4.1 Overview
9.4.2 Organ-specific Adult Stem Cells: North America Organoids Market – Revenue and Forecast to 2028 (US$ Million)
10. NORTH AMERICA ORGANOIDS MARKET – REVENUE AND FORECAST TO 2028 – COUNTRY ANALYSIS
10.1 North America Organoids Market
10.1.1 Overview
10.1.2 North America Organoids Market, by Country, 2022 & 2028 (%)
10.1.2.1 US: North America Organoids Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.1.1 Overview
10.1.2.1.2 US: North America Organoids Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.1.3 US: North America Organoids Market, by Type, 2020–2028 (US$ Million)
10.1.2.1.4 US: North America Organoids Market, by Application, 2020-2028 (US$ Million)
10.1.2.1.5 US: North America Organoids Market, by Source 2020-2028 (US$ Million)
10.1.2.2 Canada: North America Organoids Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.2.1 Overview
10.1.2.2.2 Canada: North America Organoids Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.2.3 Canada: North America Organoids Market, by Type, 2020–2028 (US$ Million)
10.1.2.2.4 Canada: North America Organoids Market, by Application, 2020-2028 (US$ Million)
10.1.2.2.5 Canada: North America Organoids Market, by Source 2020-2028 (US$ Million)
10.1.2.3 Mexico: North America Organoids Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.3.1 Overview
10.1.2.3.2 Mexico: North America Organoids Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.3.3 Mexico: North America Organoids Market, by Type, 2020–2028 (US$ Million)
10.1.2.3.4 Mexico: North America Organoids Market, by Application, 2020-2028 (US$ Million)
10.1.2.3.5 Mexico: North America Organoids Market, by Source 2020-2028 (US$ Million)
11. INDUSTRY LANDSCAPE
11.1 Overview
11.2 Growth Strategies Done by the Companies in the Market, (%)
11.3 Organic Developments
11.3.1 Overview
11.4 Inorganic Developments
11.4.1 Overview
12. COMPANY PROFILES
12.1 STEMCELL Technologies Inc.
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Definigen
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Organoid Therapeutics
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 PeproTech, Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Thermo Fisher Scientific Inc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Corning Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Merck KGaA
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 InSphero
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
13. APPENDIX
13.1 About The Insight Partners
13.2 Glossary of Terms
1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Organoids Market – by Type
1.3.2 North America Organoids Market – by Application
1.3.3 North America Organoids Market – by Source
1.3.4 North America Organoids Market – by Country
2. NORTH AMERICA ORGANOIDS MARKET – KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. NORTH AMERICA ORGANOIDS MARKET – MARKET LANDSCAPE
4.1 Overview
4.2 North America PEST Analysis
4.3 Expert’s Opinion
5. NORTH AMERICA ORGANOIDS MARKET – KEY MARKET DYNAMICS
5.1 Market Drivers
5.1.1 Increasing Demand for Tumor Modelling and Biobanking
5.1.2 Growing Adoption of Personalized Drugs
5.1.3 Rising Focus on Developing Alternatives for Animal Testing Models
5.2 Market Restraints
5.2.1 Issues Related to Incorporation of Organoids into Existing Workflows
5.2.2 Dearth of Skilled Professionals
5.3 Market Opportunities
5.3.1 Focus on Drug Discovery Activities
5.4 Future Trends
5.4.1 Combining Organoid with Organ-On-A-Chip
5.5 Impact Analysis
6. ORGANOIDS MARKET – NORTH AMERICA ANALYSIS
6.1 North America Organoids Market Revenue Forecast and Analysis
7. NORTH AMERICA ORGANOIDS MARKET – REVENUE AND FORECAST TO 2028 – BY TYPE
7.1 Overview
7.2 North America Organoids Market Revenue Share, by Type (2022 and 2028)
7.3 Stomach
7.3.1 Overview
7.3.2 Stomach: North America Organoids Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Intestine
7.4.1 Overview
7.4.2 Intestine: North America Organoids Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Liver
7.5.1 Overview
7.5.2 Liver: North America Organoids Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Pancreas
7.6.1 Overview
7.6.2 Pancreas: North America Organoids Market – Revenue and Forecast to 2028 (US$ Million)
7.7 Lung
7.7.1 Overview
7.7.2 Lung: North America Organoids Market – Revenue and Forecast to 2028 (US$ Million)
7.8 Brain
7.8.1 Overview
7.8.2 Brain: North America Organoids Market – Revenue and Forecast to 2028 (US$ Million)
7.9 Kidney
7.9.1 Overview
7.9.2 Kidney: North America Organoids Market – Revenue and Forecast to 2028 (US$ Million)
7.10 Others
7.10.1 Overview
7.10.2 Others: North America Organoids Market – Revenue and Forecast to 2028 (US$ Million)
8. NORTH AMERICA ORGANOIDS MARKET – REVENUE AND FORECAST TO 2028 – BY APPLICATION
8.1 Overview
8.2 North America Organoids Market Revenue Share, by Application (2022 and 2028)
8.3 Developmental Biology
8.3.1 Overview
8.3.2 Developmental Biology: North America Organoids Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Disease Pathology of Infectious Disease
8.4.1 Overview
8.4.2 Disease Pathology of Infectious Disease: North America Organoids Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Regenerative Medicine
8.5.1 Overview
8.5.2 Regenerative Medicine: North America Organoids Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Drug Toxicity and Efficacy Testing
8.6.1 Overview
8.6.2 Drug Toxicity and Efficacy Testing: North America Organoids Market – Revenue and Forecast to 2028 (US$ Million)
8.7 Drug Discovery and Personalized Medicine
8.7.1 Overview
8.7.2 Drug Discovery and Personalized Medicine: North America Organoids Market – Revenue and Forecast to 2028 (US$ Million)
8.8 Others
8.8.1 Overview
8.8.2 Others: North America Organoids Market – Revenue and Forecast to 2028 (US$ Million)
9. NORTH AMERICA ORGANOIDS MARKET – REVENUE AND FORECAST TO 2028 – BY SOURCE
9.1 Overview
9.2 North America Organoids Market Revenue Share, by Source (2022and 2028)
9.3 Pluripotent Stem Cells
9.3.1 Overview
9.3.2 Pluripotent Stem Cells: North America Organoids Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Organ-specific Adult Stem Cells
9.4.1 Overview
9.4.2 Organ-specific Adult Stem Cells: North America Organoids Market – Revenue and Forecast to 2028 (US$ Million)
10. NORTH AMERICA ORGANOIDS MARKET – REVENUE AND FORECAST TO 2028 – COUNTRY ANALYSIS
10.1 North America Organoids Market
10.1.1 Overview
10.1.2 North America Organoids Market, by Country, 2022 & 2028 (%)
10.1.2.1 US: North America Organoids Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.1.1 Overview
10.1.2.1.2 US: North America Organoids Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.1.3 US: North America Organoids Market, by Type, 2020–2028 (US$ Million)
10.1.2.1.4 US: North America Organoids Market, by Application, 2020-2028 (US$ Million)
10.1.2.1.5 US: North America Organoids Market, by Source 2020-2028 (US$ Million)
10.1.2.2 Canada: North America Organoids Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.2.1 Overview
10.1.2.2.2 Canada: North America Organoids Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.2.3 Canada: North America Organoids Market, by Type, 2020–2028 (US$ Million)
10.1.2.2.4 Canada: North America Organoids Market, by Application, 2020-2028 (US$ Million)
10.1.2.2.5 Canada: North America Organoids Market, by Source 2020-2028 (US$ Million)
10.1.2.3 Mexico: North America Organoids Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.3.1 Overview
10.1.2.3.2 Mexico: North America Organoids Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.3.3 Mexico: North America Organoids Market, by Type, 2020–2028 (US$ Million)
10.1.2.3.4 Mexico: North America Organoids Market, by Application, 2020-2028 (US$ Million)
10.1.2.3.5 Mexico: North America Organoids Market, by Source 2020-2028 (US$ Million)
11. INDUSTRY LANDSCAPE
11.1 Overview
11.2 Growth Strategies Done by the Companies in the Market, (%)
11.3 Organic Developments
11.3.1 Overview
11.4 Inorganic Developments
11.4.1 Overview
12. COMPANY PROFILES
12.1 STEMCELL Technologies Inc.
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Definigen
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Organoid Therapeutics
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 PeproTech, Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Thermo Fisher Scientific Inc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Corning Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Merck KGaA
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 InSphero
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
13. APPENDIX
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. US North America Organoids Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 2. US North America Organoids Market, by Application– Revenue and Forecast to 2028 (US$ Million)
Table 3. US North America Organoids Market, by Source – Revenue and Forecast to 2028 (US$ Million)
Table 4. Canada North America Organoids Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 5. Canada North America Organoids Market, by Application– Revenue and Forecast to 2028 (US$ Million)
Table 6. Canada North America Organoids Market, by Source – Revenue and Forecast to 2028 (US$ Million)
Table 7. Mexico North America Organoids Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 8. Mexico North America Organoids Market, by Application– Revenue and Forecast to 2028 (US$ Million)
Table 9. Mexico North America Organoids Market, by Source – Revenue and Forecast to 2028 (US$ Million)
Table 10. Organic Developments Done by Companies
Table 11. Inorganic Developments Done by Companies
Table 12. Glossary of Terms
Table 1. US North America Organoids Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 2. US North America Organoids Market, by Application– Revenue and Forecast to 2028 (US$ Million)
Table 3. US North America Organoids Market, by Source – Revenue and Forecast to 2028 (US$ Million)
Table 4. Canada North America Organoids Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 5. Canada North America Organoids Market, by Application– Revenue and Forecast to 2028 (US$ Million)
Table 6. Canada North America Organoids Market, by Source – Revenue and Forecast to 2028 (US$ Million)
Table 7. Mexico North America Organoids Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 8. Mexico North America Organoids Market, by Application– Revenue and Forecast to 2028 (US$ Million)
Table 9. Mexico North America Organoids Market, by Source – Revenue and Forecast to 2028 (US$ Million)
Table 10. Organic Developments Done by Companies
Table 11. Inorganic Developments Done by Companies
Table 12. Glossary of Terms
LIST OF FIGURES
Figure 1. North America Organoids Market Segmentation
Figure 2. North America Organoids Market by Country
Figure 3. North America Organoids Market Overview
Figure 4. Intestine is The Largest Share of Type Segment in North America Organoids Market
Figure 5. The US Expected to Show Remarkable Growth During Forecast Period
Figure 6. North America: PEST Analysis
Figure 7. North America Experts’ Opinion
Figure 8. North America Organoids Market Impact Analysis of Drivers and Restraints
Figure 9. North America Organoids Market – Revenue Forecast and Analysis – 2020–2028
Figure 10. North America Organoids Market Revenue Share, by Type (2022 and 2028)
Figure 11. Stomach: North America Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Intestine: North America Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Liver: North America Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Pancreas: North America Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Lung: North America Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Brain: North America Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Kidney: North America Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Others: North America Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. North America Organoids Market Revenue Share, by Application (2022 and 2028)
Figure 20. Developmental Biology: North America Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Disease Pathology of Infectious Disease: North America Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Regenerative Medicine: North America Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Drug Toxicity and Efficacy Testing: North America Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Drug Discovery and Personalized Medicine: North America Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Others: North America Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. North America Organoids Market Revenue Share, by Source (2022 and 2028)
Figure 27. Pluripotent Stem Cells: North America Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Organ-specific Adult Stem Cells: North America Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. North America Organoids Market, by Key Country – Revenue (2022) (US$ Million)
Figure 30. North America Organoids Market, by Country, 2022 & 2028 (%)
Figure 31. US: North America Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 32. Canada: North America Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 33. Mexico: North America Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 34. Growth Strategies Done by the Companies in the Market, (%)
Figure 1. North America Organoids Market Segmentation
Figure 2. North America Organoids Market by Country
Figure 3. North America Organoids Market Overview
Figure 4. Intestine is The Largest Share of Type Segment in North America Organoids Market
Figure 5. The US Expected to Show Remarkable Growth During Forecast Period
Figure 6. North America: PEST Analysis
Figure 7. North America Experts’ Opinion
Figure 8. North America Organoids Market Impact Analysis of Drivers and Restraints
Figure 9. North America Organoids Market – Revenue Forecast and Analysis – 2020–2028
Figure 10. North America Organoids Market Revenue Share, by Type (2022 and 2028)
Figure 11. Stomach: North America Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Intestine: North America Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Liver: North America Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Pancreas: North America Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Lung: North America Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Brain: North America Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Kidney: North America Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Others: North America Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. North America Organoids Market Revenue Share, by Application (2022 and 2028)
Figure 20. Developmental Biology: North America Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Disease Pathology of Infectious Disease: North America Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Regenerative Medicine: North America Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Drug Toxicity and Efficacy Testing: North America Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Drug Discovery and Personalized Medicine: North America Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Others: North America Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. North America Organoids Market Revenue Share, by Source (2022 and 2028)
Figure 27. Pluripotent Stem Cells: North America Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Organ-specific Adult Stem Cells: North America Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. North America Organoids Market, by Key Country – Revenue (2022) (US$ Million)
Figure 30. North America Organoids Market, by Country, 2022 & 2028 (%)
Figure 31. US: North America Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 32. Canada: North America Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 33. Mexico: North America Organoids Market – Revenue and Forecast to 2028 (US$ Million)
Figure 34. Growth Strategies Done by the Companies in the Market, (%)
